|Articles|May 18, 2020

What COVID-19 changes will stay permanent?

Anders Gilberg, senior vice president of government affairs for MGMA, discusses whether loosening of HIPAA and telehealth restrictions will continue after the COVID-19 pandemic subsides.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Physicians finally got a Medicare raise. Keeping it is the hard part.

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

When prior authorization sparks ‘outrage and frustration’

ADA ousts researchers then apologizes; Medicare Advantage reverses 95% of appealed denials; AMA takes on AI and corporate medicine — Morning Medical Update Weekly Recap

What COVID-19 changes will stay permanent?

Related Content

Are you prepared for a malpractice nightmare?

Anthony Orsini, D.O., joins Medical Economics Editorial Advisory Board

When prior authorization sparks ‘outrage and frustration’

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

Fans catching football fever; a necessary food group for aging; potential chemical dangers from e-cigarettes — Morning Medical Update

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

Physicians finally got a Medicare raise. Keeping it is the hard part.

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

When prior authorization sparks ‘outrage and frustration’

ADA ousts researchers then apologizes; Medicare Advantage reverses 95% of appealed denials; AMA takes on AI and corporate medicine — Morning Medical Update Weekly Recap